Lansing Street Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,978
| Closed | -$516K | – | 141 |
|
|
2024
Q4 | $516K | Sell |
5,978
-2,821
| -32% | -$243K | 0.18% | 68 |
|
|
2024
Q3 | $836K | Buy |
8,799
+35
| +0.4% | +$3.33K | 0.31% | 49 |
|
|
2024
Q2 | $802K | Sell |
8,764
-2,306
| -21% | -$211K | 0.33% | 49 |
|
|
2024
Q1 | $1M | Sell |
11,070
-3,465
| -24% | -$314K | 0.45% | 42 |
|
|
2023
Q4 | $1.18M | Buy |
+14,535
| New | +$1.18M | 0.62% | 35 |
|
|
2023
Q2 | $1.91M | Sell |
24,253
-1,237
| -5% | -$97.4K | 1.11% | 23 |
|
|
2023
Q1 | $1.98M | Sell |
25,490
-820
| -3% | -$63.7K | 1.24% | 23 |
|
|
2022
Q4 | $2.05M | Sell |
26,310
-5,923
| -18% | -$460K | 1.4% | 21 |
|
|
2022
Q3 | $2.17M | Buy |
32,233
+9,418
| +41% | +$633K | 1.68% | 15 |
|
|
2022
Q2 | $1.75M | Buy |
22,815
+2,572
| +13% | +$198K | 1.36% | 19 |
|
|
2022
Q1 | $1.7M | Buy |
+20,243
| New | +$1.7M | 1.08% | 25 |
|